A recent population-based surveillance study from six states found that 61.4% of individuals with SCD had SCA, 28.3% had Hb SC, 8.5% had Hb Sβ+ thalassemia, and 1.8% had another compound heterozygous form of SCD5. This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.